Insider Shareholders with Direct Ownership of Amneal Pharmaceuticals, Inc. (AMRX)
This section provides a comprehensive overview of the insiders with direct ownership of Amneal Pharmaceuticals, Inc. (AMRX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Amneal Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Gautam Patel
Director |
1,886,320 | 33,778,067 | 1,728,886 $14.3 Million | 12 |
Apr 01, 2025
Reduced 4.42%
|
|
Chintu Patel
Co-CEO |
822,302 | 320,835 | 864,033 $7.15 Million | 6 |
Mar 04, 2025
Reduced 5.11%
|
|
Chirag K. Patel
President & Co-CEO |
822,302 | 326,888 | 857,980 $7.1 Million | 6 |
Mar 04, 2025
Reduced 5.23%
|
|
Paul M Meister
Director |
346,120 | 0 | 727,692 $6.03 Million | 4 |
May 10, 2024
Added 12.82%
|
|
Tasos Konidaris
Executive Vice President & CFO |
971,353 | 349,471 | 621,882 $5.15 Million | 19 |
Mar 05, 2025
Reduced 13.85%
|
|
Nikita Shah
Executive Vice President |
719,955 | 461,613 | 438,069 $3.63 Million | 34 |
Mar 04, 2025
Reduced 4.02%
|
|
Joseph Todisco
Executive Vice President |
153,346 | 80,176 | 327,194 $2.71 Million | 15 |
May 07, 2022
Reduced 0.48%
|
|
Ted C Nark
Director |
238,205 | 0 | 300,771 $2.49 Million | 4 |
May 10, 2024
Added 20.27%
|
|
Andrew S Boyer
Executive Vice President |
804,105 | 623,932 | 290,106 $2.4 Million | 40 |
Mar 05, 2025
Reduced 30.11%
|
|
Jeffrey P. George
Director |
245,727 | 0 | 269,537 $2.23 Million | 5 |
May 10, 2024
Added 22.1%
|
|
John Kiely
Director |
274,233 | 17,058 | 267,175 $2.21 Million | 7 |
Nov 22, 2024
Reduced 6.0%
|
|
Shlomo Yanai
Director |
245,727 | 0 | 245,727 $2.03 Million | 5 |
May 10, 2024
Added 23.73%
|
|
Emily Peterson Alva
Director |
238,205 | 80,000 | 170,771 $1.41 Million | 5 |
Mar 05, 2025
Reduced 31.9%
|
|
Deborah M. Autor
Director |
131,402 | 78,000 | 53,402 $442,168 | 6 |
Nov 22, 2024
Reduced 38.36%
|
|
Jason B. Daly
EVP, Chief Legal Officer |
270,846 | 238,240 | 32,606 $269,977 | 12 |
Mar 06, 2025
Reduced 59.01%
|
|
Stephen Manzano
SVP, General Counsel |
16,490 | 5,796 | 10,694 $88,546 | 2 |
Feb 27, 2021
Reduced 35.15%
|
|
J Kevin Buchi
Director |
238,205 | 262,072 | 0 $0 | 5 |
Mar 10, 2025
Reduced 100.0%
|